Drug Trial Results: Positive clinical trial outcomes often drive stock prices up, while failures can cause significant drops.

FDA Approval Decisions: Receiving FDA approval for a drug typically leads to increased investor confidence and higher stock value.

Competition: The presence of competing drugs or therapies in the market can negatively impact ATOGY.US's market share and stock price.

Market Sentiment: Overall investor optimism or pessimism toward the biotechnology sector can influence ATOGY.US stock valuations.

Financial Performance: Strong revenue growth, profitability, and positive earnings reports generally boost stock prices.

Partnerships and Collaborations: Forming strategic alliances with other pharmaceutical companies can enhance ATOGY.US's capabilities and stock appeal.

Regulatory Changes: Changes in healthcare regulations can affect the market environment for ATOGY.US's products and its stock performance.

Economic Conditions: Broader economic factors, such as interest rates and inflation, can impact investor decisions and stock market valuations.